Stay updated with breaking news from Robertg Burrows. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Government purchases for the Strategic National Stockpile, the country’s emergency medical reserve, have largely been driven by the demands and interests of a handful of biotech firms.
Government purchases for the Strategic National Stockpile, the country’s emergency medical reserve, have largely been driven by the demands and interests of a handful of biotech firms.
A year ago, President Donald J. Trump declared a national emergency, promising a wartime footing to combat the coronavirus.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Emergent BioSolutions and Mount Sinai Health System Announce Initiation of DOD-Funded Clinical ... Emergent BioSolutionsDecember 29, 2020 GMT GAITHERSBURG, Md. and NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) and Mount Sinai Health System today announced initiation of the clinical program to evaluate Emergent’s COVID-19 Human Hyperimmune Globulin (COVID-HIG) product candidate in the first of two Phase 1 studies to support its use for potential post-exposure prophyl...
Home / Top News / Emergent BioSolutions and Mount Sinai Health System Announce Initiation of DOD-Funded Clinical Program to Evaluate COVID-19 Human Hyperimmune Globulin (COVID-HIG) Product Candidate for Prophylaxis Emergent BioSolutions and Mount Sinai Health System Announce Initiation of DOD-Funded Clinical Program to Evaluate COVID-19 Human Hyperimmune Globulin (COVID-HIG) Product Candidate for Prophylaxis GAITHERSBURG, Md. and NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions (NYSE: EBS) and Mount Sinai Health System today announced initiation of the clinical program to ev...